National Eye Institute (NIH)
Overview
The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is to eliminate vision loss and improve quality of life through vision research. NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research. NEI was established in 1968 as the nation's leading supporter of eye health and vision research projects. These projects include basic science research into the fundamental biology of the eye and the visual system. NEI also funds translational and clinical research aimed at developing and testing therapies for eye diseases and disorders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| New Scale Technologies, Inc. | Apr 2016 | Grant | Co-investor |
| Grannus Therapeutics | Dec 2021 | Grant | Co-investor |
| AiVita Biomedical | Sep 2016 | Grant | Co-investor |
| iVeena Delivery Systems | Sep 2025 | Grant | Co-investor |
| ONL Therapeutics | Nov 2014 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Eye Institute (NIH) based?
National Eye Institute (NIH) is headquartered in Bethesda, Maryland, United States.
When was National Eye Institute (NIH) founded?
National Eye Institute (NIH) was founded in 1968.
How many portfolio companies does National Eye Institute (NIH) have?
National Eye Institute (NIH) has 24 portfolio companies in Caplight's dataset.
What are some companies in National Eye Institute (NIH)'s portfolio?
Portfolio companies visible on Caplight include New Scale Technologies, Inc., Grannus Therapeutics, AiVita Biomedical, iVeena Delivery Systems, ONL Therapeutics.
What was National Eye Institute (NIH)'s most recent investment shown here?
National Eye Institute (NIH)'s most recent investment in this portfolio sample was in iVeena Delivery Systems in 2025.
What sectors does National Eye Institute (NIH) focus on?
National Eye Institute (NIH) focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does National Eye Institute (NIH) focus on?
National Eye Institute (NIH) typically invests at the Early stage.
What is National Eye Institute (NIH)'s AUM?
National Eye Institute (NIH)'s assets under management are estimated between $500.0M and $1.0B.